Oncology / Vectibix / Pitch
Pitch Concept to encourage doctors to identify patients that were wild-type RAS.
Integrated Pitch Concepts/iVis/website
Pitch Concept to encourage doctors to identify patients that were wild-type RAS.
Pitch Concept to encourage doctors to identify patients that were wild-type RAS.
Vectibix is indicated for the treatment of patients with wild-type RAS (defined as wild-type in both KRAS and NRAS as determined by an FDA-approved test for this use) metastatic colorectal cancer (mCRC): as 1L terapy in combination with FOLFOX.
-
For These are concepts chosen for a Vectibix pitch
Up Next: